Search Results - "Janus"

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor by Carine M. Lama, MS, Miguel A. Hernandez-Rovira, BSc, Neha Mehta-Shah, MD, Aaron Russell, MD, Amy C.M. Musiek, MD

Connect to this object online.

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease by Huo R, Guo Q, Hu J, Li N, Gao R, Mi L, Zhang Z, Liu H, Guo Z, Zhao H, Zhang L, Xu K

Connect to this object online.

Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo by Samaka RM, Basha MA, Menesy D

Connect to this object online.

Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis by Haruka Tsuchiya, Mineto Ota, Haruka Takahashi, Hiroaki Hatano, Megumi Ogawa, Sotaro Nakajima, Risa Yoshihara, Tomohisa Okamura, Shuji Sumitomo, Keishi Fujio

Connect to this object online.

Effectiveness of  Janus kinase  inhibitors in  rheumatoid  arthritis:  systematic review  and  meta-analysis by A. E. Cheberda, D. Yu. Belousov

Connect to this object online.

Janus-kinase Inhibitors in Pathogenesis and Management of Chronic Urticaria: A Review of the Literature by Sepideh Darougar, Seyed Karen Hashemitari, Sara Montazeri Namin

Connect to this object online.

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor by Singer J, Al-Fayoumi S, Ma H, Komrokji R, Mesa R, Verstovsek S

Connect to this object online.

The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor by article Editorial

Connect to this object online.

Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis by Takashi Hashimoto, Kent Sakai, Kristen M. Sanders, Gil Yosipovitch, Tasuku Akiyama

Connect to this object online.

Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient by Sineida Berbert Ferreira, Rachel Berbert Ferreira, Afonso Cesar Neves Neto, Silvana Martins Caparroz Assef, Morton Scheinberg

Connect to this object online.

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib by Miguel Nogueira, Tiago Torres

Connect to this object online.

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis by Elizabeth J. Klein, MD, Dolly Taiwò, MD, Efe Kakpovbia, MD, Melissa Laughter, MD, PhD, Ambika Nohria, BA, Kristen I. Lo Sicco, MD

Connect to this object online.

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick HY. Chong, BSc, Siddhartha Sood, HBSc, Muskaan Sachdeva, MD, Jensen Yeung, MD

Connect to this object online.

Alginate‐based complex fibers with the Janus morphology for controlled release of co‐delivered drugs by Wing-Fu Lai, Eric Huang, Kwok-Ho Lui

Connect to this object online.

Janus kinase inhibitors suppress cancer cachexia‐associated anorexia and adipose wasting in mice by Gurpreet K. Arora, Arun Gupta, Tong Guo, Aakash Y. Gandhi, Aaron Laine, Dorothy L. Williams, Chul Ahn, Puneeth Iyengar, Rodney E. Infante

Connect to this object online.

Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes by Ankit Srivastava, Mona Ståhle, Andor Pivarcsi, Enikö Sonkoly

Connect to this object online.

Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases by Annie Mayence, Jean Jacques Vanden Eynde

Connect to this object online.

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review by Nem Kumar Jain, Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, Balakumar Chandrasekaran, Biswa Mohan Sahoo, Anandhalakshmi Subramanian, Neelaveni Thangavel, Afaf Aldahish, Kumarappan Chidambaram, M. Alagusundaram, Santosh Kumar, Palani Selvam

Connect to this object online.

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis by Sang-Doo Lee, MD, Hye-Jin Ahn, MD, PhD, Min Kyung Shin, MD, PhD

Connect to this object online.

Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications by Kei Xian Tan, Michael K. Danquah, Jaison Jeevanandam, Ahmed Barhoum

Connect to this object online.